The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 22, 2022
Filed:
Nov. 11, 2019
Applicant:
H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL (US);
Inventor:
Alan F. List, Tampa, FL (US);
Assignee:
H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); G01N 33/53 (2006.01); G01N 33/564 (2006.01); G01N 33/574 (2006.01); G01N 33/68 (2006.01); G01N 33/573 (2006.01); C12Q 1/6809 (2018.01); C12Q 1/06 (2006.01); C12Q 1/6886 (2018.01); C07K 14/545 (2006.01);
U.S. Cl.
CPC ...
G01N 33/564 (2013.01); C12Q 1/68 (2013.01); G01N 33/53 (2013.01); G01N 33/57426 (2013.01); G01N 33/57484 (2013.01); G01N 33/68 (2013.01); G01N 33/6893 (2013.01); C07K 14/545 (2013.01); C12Q 1/06 (2013.01); C12Q 1/6809 (2013.01); C12Q 1/6886 (2013.01); G01N 33/573 (2013.01); G01N 33/574 (2013.01); G01N 2333/964 (2013.01); G01N 2333/96466 (2013.01);
Abstract
Disclosed are methods for diagnosing a myelodysplastic syndrome (MDS) in a subject. In some embodiments, the method involves assaying a sample from the subject to detect inflammasome activation, wherein an increase in inflammasome activation in the sample compared to a control is an indication of MDS in the subject. The disclosed methods can further involve treating the subject for MDS if an increase in inflammasome activation is detected.